Latest Lupus erythematosus Stories
Episode highlights the importance for men and their physicians to consider lupus diagnosis New York, NY (PRWEB) September 02, 2011 Lupus Research Institute
ANAHEIM, Calif., July 28, 2011 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) announced today that executive management will present at the Canaccord Genuity Growth Conference to be held August 9-11, 2011 at the InterContinental Boston in Boston, MA. Don M.
To view the Social Media Release, click here: http://smr.newswire.ca/en/lupus-canada/first-new-lupus-treatment-in-almost-50-years MARKHAM, ON, July 12, 2011 /PRNewswire/ - Health Canada's recent approval of BENLYSTA(TM) marks the first new treatment available in almost 50 years to the over 1:1000 Canadian men, women and children who are living with Systemic Lupus Erythematosus (SLE) an autoimmune disease with no known cause or cure.
Mayor Michael R. Bloomberg this week presented the S.L.E.
To view the Social Media Release, click here: http://smr.newswire.ca/en/lupus-canada/take-a-step-to-conquer-lupus MARKHAM, ON, May 6 /PRNewswire/ - In the month of May residents in communities across Canada will participate in Lupus Canada's most important public awareness and fundraising event, Walk for Lupus.
HAYWARD, Calif., May 3, 2011 /PRNewswire/ -- Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), today announced financial results and business highlights for the quarter ended March 31, 2011.
- An uxorious, effeminate, or spiritless man.
- A timorous, cowardly fellow.